Mitsuhashi A - Search Results

1

Antipodoplanin antibody enhances the antitumor effects of CTLA-4 blockade against malignant mesothelioma by natural killer cells.

Yoneda H, Mitsuhashi A, Yoshida A, Ogino H, Itakura S, Nguyen NT, Nokihara H, Sato S, Shinohara T, Hanibuchi M, Abe S, Kaneko MK, Kato Y, Nishioka Y. Yoneda H, et al. Among authors: mitsuhashi a. Cancer Sci. 2024 Feb;115(2):357-368. doi: 10.1111/cas.16046. Epub 2023 Dec 26. Cancer Sci. 2024. PMID: 38148492 Free PMC article.

2

Programmed death (PD)-1/PD-ligand 1 blockade mediates antiangiogenic effects by tumor-derived CXCL10/11 as a potential predictive biomarker.

Mitsuhashi A, Kondoh K, Horikawa K, Koyama K, Nguyen NT, Afroj T, Yoneda H, Otsuka K, Ogino H, Nokihara H, Shinohara T, Nishioka Y. Mitsuhashi A, et al. Cancer Sci. 2021 Dec;112(12):4853-4866. doi: 10.1111/cas.15161. Epub 2021 Oct 23. Cancer Sci. 2021. PMID: 34628702 Free PMC article.

3

S-1 eliminates MDSCs and enhances the efficacy of PD-1 blockade via regulation of tumor-derived Bv8 and S100A8 in thoracic tumor.

Nguyen NT, Mitsuhashi A, Ogino H, Kozai H, Yoneda H, Afroj T, Sato S, Nokihara H, Shinohara T, Nishioka Y. Nguyen NT, et al. Among authors: mitsuhashi a. Cancer Sci. 2023 Feb;114(2):384-398. doi: 10.1111/cas.15620. Epub 2022 Nov 11. Cancer Sci. 2023. PMID: 36285504 Free PMC article.

4

Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.

Kozai H, Ogino H, Mitsuhashi A, Nguyen NT, Tsukazaki Y, Yabuki Y, Ozaki R, Yoneda H, Sato S, Hanibuchi M, Shinohara T, Nokihara H, Nishioka Y. Kozai H, et al. Among authors: mitsuhashi a. Thorac Cancer. 2024 Feb;15(5):369-378. doi: 10.1111/1759-7714.15200. Epub 2023 Dec 26. Thorac Cancer. 2024. PMID: 38146645 Free PMC article.

5

The therapeutic efficacy of S-1 against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.

Van TT, Hanibuchi M, Kakiuchi S, Sato S, Kuramoto T, Goto H, Mitsuhashi A, Nishioka Y, Akiyama S, Sone S. Van TT, et al. Among authors: mitsuhashi a. Cancer Chemother Pharmacol. 2011 Aug;68(2):497-504. doi: 10.1007/s00280-010-1503-x. Epub 2010 Nov 16. Cancer Chemother Pharmacol. 2011. PMID: 21079960 Free PMC article.

6

Anti-PD-1 antibody combined with chemotherapy suppresses the growth of mesothelioma by reducing myeloid-derived suppressor cells.

Otsuka K, Mitsuhashi A, Goto H, Hanibuchi M, Koyama K, Ogawa H, Ogino H, Saijo A, Kozai H, Yoneda H, Tobiume M, Kishuku M, Ishizawa K, Nishioka Y. Otsuka K, et al. Among authors: mitsuhashi a. Lung Cancer. 2020 Aug;146:86-96. doi: 10.1016/j.lungcan.2020.05.023. Epub 2020 May 21. Lung Cancer. 2020. PMID: 32526602

7

Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Afroj T, Mitsuhashi A, Ogino H, Saijo A, Otsuka K, Yoneda H, Tobiume M, Nguyen NT, Goto H, Koyama K, Sugimoto M, Kondoh O, Nokihara H, Nishioka Y. Afroj T, et al. Among authors: mitsuhashi a. J Immunol. 2021 Mar 15;206(6):1204-1214. doi: 10.4049/jimmunol.2000909. Epub 2021 Jan 27. J Immunol. 2021. PMID: 33504617 Free PMC article.

8

Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma.

Yoneda H, Nokihara H, Mitsuhashi A, Ozaki R, Yabuki Y, Ogino H, Otsuka K, Nishioka Y. Yoneda H, et al. Among authors: mitsuhashi a. BMC Pulm Med. 2021 Nov 15;21(1):373. doi: 10.1186/s12890-021-01746-6. BMC Pulm Med. 2021. PMID: 34781910 Free PMC article.

9

A case of pulmonary pleomorphic carcinoma with preexisting interstitial pneumonia successfully treated with pembrolizumab.

Sako M, Nokihara H, Kondo K, Mitsuhashi A, Ozaki R, Yabuki Y, Abe A, Yoneda H, Ogino H, Otsuka K, Uehara H, Nishioka Y. Sako M, et al. Among authors: mitsuhashi a. Thorac Cancer. 2022 Jan;13(1):129-132. doi: 10.1111/1759-7714.14243. Epub 2021 Dec 3. Thorac Cancer. 2022. PMID: 34859591 Free PMC article.

10

Radiation therapy induces an abscopal effect and upregulates programmed death-ligand 1 expression in a patient with non-small cell lung cancer.

Morita Y, Saijo A, Nokihara H, Mitsuhashi A, Yoneda H, Otsuka K, Ogino H, Bando Y, Nishioka Y. Morita Y, et al. Among authors: mitsuhashi a. Thorac Cancer. 2022 Apr;13(7):1079-1082. doi: 10.1111/1759-7714.14330. Epub 2022 Jan 22. Thorac Cancer. 2022. PMID: 35064748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

128 results

Search Page